Document is current
Any future updates will be listed below
-
Authors
Klonteig, Sandra E. https://orcid.org/0000-0003-1997-5206
Walsh, Annabel E. L.
Jonassen, Rune
Browning, Michael
Harmer, Catherine J.
Martens, Marieke A. G.
-
Funding
Funding for this research was provided by:
OsloMet - Oslo Metropolitan University
- License Information
-
More Information
Article History
Received: 30 May 2025
Accepted: 11 December 2025
First Online: 23 December 2025
Declarations
:
: The study was approved by the NHS Research Ethics Committee (reference no. 13/SC/0569) and the University of Oxford Clinical Trials and Research Governance Team (reference no. 13/SC/0569), and performed in accordance with Declaration of Helsinki.
: All participants gave voluntary written consent to take part of the study.
: All participants gave voluntary written consent to publish non-identifiable data from the study.
: CH received consultancy fees from P1vital Ltd., Janssen Pharmaceuticals, UCB, and Lundbeck. MB received travel expenses from Lundbeck for attending conferences and has served as a consultant for Johnson & Johnson, the Centre for Human Drug Research, Engrail Therapeutics, Alto Neuroscience, and P1vital Ltd. Other authors have no relevant financial or non-financial interests to disclose.
